Changes in bone mineral density and bone turnover markers ... - ISBMR
Recommend Documents
BONE TURNOVER MARKERS WITH OSTEOARTHRITIS OF. THE HAND AND KNEE IN PRE- AND PERIMENOPAUSAL WOMEN. MARYFRAN SOWERS ...
Dec 13, 2005 - The data on bone mineral density (BMD) in children after HCT ..... at 6 months or 1 yr; recovery group, in which there was a substantial LBMDA ...
tion of activity of interstitial cells (Leydig cells) during ageing. Among other ...... 2000;34:273â278. 23. Wacker WK, Barden HS, Franz JR, Ergun DL. Precision.
Original. Introduction. Impaired renal function is a well-established risk factor for reduced bone mineral density (BMD) and ... Patients with CKD are at increased risk of bone loss, even with minimal ... osteoporosis should and could be included in
Sep 20, 2016 - Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.
Aug 17, 2012 - osteoarthropathy endemic in Se- and iodine-deficient ar- eas of Asia (8). ...... liams GR 2000 Thyroid hormones regulate hypertrophic chondro-.
May 14, 2017 - tools for monitoring cell therapy efficacy in bone nonunions, but studies with ... healing, quite a high incidence of delayed and nonunion of.
2Department of Nuclear Medicine; 3The Liver & Hepatobiliary Unit, Queen. Elizabeth Hospital, Birmingham; 4Department of Clinical Chemistry, Royal. Liverpool ...
estradiol valerate and 1 mg cyproterone acetate), D group (vitamin D3,. 300 IU/day), HRTD group (both of the above), and placebo group. (calcium lactate, 500 ...
Apr 7, 2014 - loss, as well as patients previously treated with teriparatide. Bisphosphonates were discontinued for medical reasons. (GI intolerance) or ...
Jorge Inostroza & Karen Basfi-fer & Karin Papapietro &. 10. Jorge Rojas & Fernando Pizarro & Manuel Olivares. 11. Received: 14 May 2008 /Accepted: 7 July ...
Feb 5, 2009 - analogue treatment for patients only, and bone age assessed by X-ray .... LHRH analogue due to central precocious puberty. (1 with fair control ...
decreasing testosterone to castrate levels. ADT also markedly ..... cohort of patients was small, meaning that this research has to be expanded using a larger ...
Nov 16, 2011 - With Denosumab Treatment and Risk Reduction for ... Address correspondence to: Matthew Austin, Amgen Inc., One Amgen Center Drive, MS 24-2-C, Thousand Oaks, CA 91320 ..... of a steering committee for Amgen and has received consulting .
of its origin, are galactorrhea, oligo- or amenorrhea and ste- rility in women and impotence, ... In order to confirm HP serum PRL levels were meas- ured in all ... (normal distribution) and Wilcoxon test (deviated distribution) to test statistical .
... RICHARD D. WASNICH, PAUL MILLER,. DESMOND E. THOMPSON, AND PHILIP D. ROSS. University of Maryland School of Medicine (M.C.H.), Baltimore, ...
myelofibrosis and autoimmune diseases, although only. Caucasians with scleroderma, selecting controls matched. 30% of them had regression of bone marrow ...
ducted a study to determine the effects of scleroderma appeared with steroids in ... by self-report concerning leisure time and activities of. Aplastic anemia and ...
Cramm JM, Bornscheuer L, Selivanova A, Lee J (2015) The health of India's .... Richard JR, Dhir R (2004) Prostate cancer screening parameters in a high-risk ...
Under the conditions of a space flight (SF), the lack of supporting loads on the skeleton has an adverse effect on the strength of bones and structure of the bone ...
Oct 12, 2010 - Fjordungssjukrahusid Akureyri; Portugal: M.E. Simões,. Instituto Portugues De Reumatologia, Lisboa; J. Melo-. Gomes, Servimed, Lisboa; J.C. ...
Oct 12, 2010 - reported by Cosman et al. in patients pretreated with raloxifene .... Benhamou, Hôpital Porte Madeleine, Orleans; C. Ribot,. Hôpital Paule de ...
Subsequent reloading restores reduced bone formation and suppresses ... Keywords: Unloading, Reloading, Trabecular Bone, Bone Marrow, Tail Suspension.
Changes in bone mineral density and bone turnover markers ... - ISBMR
... IP: 117.199.73.145] || Click here to download free Android application for this ..... â1.6±3.8. â3.1±9.8. 0.729. â3.6±7.5. â2.2±8.7. 0.706. â3.8±7.7. â1.5±8.9.
[Downloaded free from http://www.ijem.in on Thursday, March 05, 2015, IP: 117.199.73.145] || Click here to download free Android application for this journal
Original Article
Changes in bone mineral density and bone turnover markers in patients undergoing hematopoietic stem cell transplant Aditi Pandit, M. K. Garg, N. Kotwal1, K. S. Brar1, Abhay Gundgurthi1, A. K. Sharma2, Sanjeevan Sharma2 Commandant, Military Hospital, Shillong, Meghalaya, Departments of 1Endocrinology and 2Hematology, Army Hospital Research and Referral, New Delhi, India
A B S T R A C T Introduction: Hematopoietic stem cell transplant (HSCT) is frequently complicated by endocrine abnormalities and loss of bone mass. This prospective study was conducted to evaluate the bone loss post‑HSCT. Materials and Methods: A total of 50 patients was evaluated pretransplantation, and 25 had HSCT (17 males, 8 females; 19 allogenic, 6 autologous). Bone mineral density (BMD) and bone markers were measured at baseline, 3–6 months and 12 months. Results: The mean age and body mass index were 25.1 ± 16.3 years and 19.4 ± 4.5 kg/m2, respectively. There were 15 adults (60%), and 10 adolescents (40%). There was a significant decline in BMD from the baseline at total femur (−8.7%; P
